Head of Pharmacovigilance 3-6 month contract

£50000 - £100000 per annum
Oct 13, 2016
Nov 12, 2016
Andrew Tattersall
Jobseeker Type
Organization Type
Contract Type
Full Time

Head of Pharmacovigilance 3-6 month contract

I'm currently working with a rapidly expanding CRO who have a Senior Pharmacovigilance 3-6 month contract role.

The position is post marketing focused, and would suit someone who has ideally worked as a QPPV before, has hand-on PSMF management and other tasks with the safety database, etc. The company are currently at acquisition stage, thus are in a healthy state, have a diverse project range with an oncology focus and they are also at the size were you can still influence and input into their pharmacovigilance processes.

To apply or for more information please contact Andrew Tattersall at NonStop, either by calling me for a confidential discussion on +41 (0)435 08 08 17 or email your up-to-date Word doc. CV to drugsafety@nonstop-pharma.com, quoting the job reference above.

I'm Andrew Tattersall, the specialist head hunter/recruitment consultant for pharmacovigilance/drug safety for Pharmaceutical & Biotechnology companies, as well as Clinical Research Organisations and Medical Device companies. I operate between offices in Prague, Zug and London, and offer contingency and retained search services throughout Europe exclusively in this area, with a focus on Germany and Switzerland. Whether you are looking for potential career options, honest guidance on salary, advice on how to present your CV, or need assistance with positions you are recruiting for, contact me. NonStop is a one of the largest and fastest growing specialised life sciences recruitment companies in Europe. We are proud members of the APSCo life sciences group who ensure we meet the highest quality standards within the recruitment industry. We are a Swiss company, and our offices are located in the UK, Switzerland and the Czech Republic and we hold labour leasing licences across Europe. Please visit our website for a full list of the niche markets we cover.